Thermo Fisher Scientific is buying Solventum’s purification & filtration unit for $4.1 billion in cash, strengthening its ...

Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides ...

Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on ...

GlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.

Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company’s largest active shareholder, commented on ...

Investing.com -- Activist investor Trian Fund Management is reportedly planning to urge Solventum to separate additional businesses following the company’s $4.1 billion deal to sell its filtration ...

Thermo Fisher Scientific has a market capitalization of about $203.5 billion. Shares (NYSE: TMO) at midday Wednesday were trading around $532, which is near the bottom of their 52-week range.

Solventum's $4.1B divestment to Thermo Fisher enhances financial stability, boosts EPS, and strengthens its long-term growth ...

Oil futures settled Tuesday at their lowest level of the year, with the economy and energy demand expected to take a hit from proposed U.S. tariffs on Canada and Mexico that may come into effect next ...

Shares of Solventum surged Tuesday after it agreed to sell its filtration and purification business to Thermo Fisher ...

The price of bitcoin fell below $90,000 and other cryptocurrencies saw large drops Tuesday morning, erasing some of the gains ...

The trend of corporate pruning in med tech continues with Solventum Corp.’s decision to sell its purification and filtration business to Thermo Fisher Scientific Inc. for $4.1 billion. The ...